HER2 Support Group Forums - View Single Post - Cardiovascular considerations crucial for CML TKI patients

News · 01-22-2016, 03:20 PM

A review of BCR–ABL1 tyrosine kinase inhibitors highlights the need to consider cardiovascular adverse event risk profiles when prescribing for patients with chronic myeloid leukaemia.

More...

01-22-2016, 03:20 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,984	Cardiovascular considerations crucial for CML TKI patients A review of BCR–ABL1 tyrosine kinase inhibitors highlights the need to consider cardiovascular adverse event risk profiles when prescribing for patients with chronic myeloid leukaemia. More...